Title : Effects of Vildagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on the Parameters of Glucose Metabolism and the Cardio-Ankle Vascular Index in Individuals with Type 2 Diabetes - Nagayama_2024_J.Clin.Med_13_ |
Author(s) : Nagayama D , Kawana H , Watanabe Y , Horikawa O , Ohira M , Saiki A |
Ref : J Clin Med , 13 : , 2024 |
Abstract : Nagayama_2024_J.Clin.Med_13_ |
ESTHER : Nagayama_2024_J.Clin.Med_13_ |
PubMedSearch : Nagayama_2024_J.Clin.Med_13_ |
PubMedID: 38256615 |
Nagayama D, Kawana H, Watanabe Y, Horikawa O, Ohira M, Saiki A (2024)
Effects of Vildagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on the Parameters of Glucose Metabolism and the Cardio-Ankle Vascular Index in Individuals with Type 2 Diabetes
J Clin Med
13 :
Nagayama D, Kawana H, Watanabe Y, Horikawa O, Ohira M, Saiki A (2024)
J Clin Med
13 :